KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Non-Current Deferred Tax Liability (2016 - 2024)

Staar Surgical (STAA) has disclosed Non-Current Deferred Tax Liability for 14 consecutive years, with $297000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Non-Current Deferred Tax Liability fell 72.42% year-over-year to $297000.0, compared with a TTM value of $297000.0 through Dec 2024, down 72.42%, and an annual FY2024 reading of $297000.0, down 72.42% over the prior year.
  • Non-Current Deferred Tax Liability was $297000.0 for Q4 2024 at Staar Surgical, down from $1.1 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $1.6 million in Q3 2022 and bottomed at $222000.0 in Q1 2021.
  • Average Non-Current Deferred Tax Liability over 4 years is $888764.7, with a median of $1.1 million recorded in 2024.
  • The sharpest move saw Non-Current Deferred Tax Liability soared 600.0% in 2022, then tumbled 72.42% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $811000.0 in 2021, then surged by 83.6% to $1.5 million in 2022, then fell by 27.67% to $1.1 million in 2023, then crashed by 72.42% to $297000.0 in 2024.
  • Business Quant data shows Non-Current Deferred Tax Liability for STAA at $297000.0 in Q4 2024, $1.1 million in Q3 2024, and $1.1 million in Q2 2024.